Sen­ate opens probe in­to how high-risk re­search pos­es na­tion­al se­cu­ri­ty threats

Lead­ers of the Sen­ate Home­land Se­cu­ri­ty and Gov­ern­men­tal Af­fairs Com­mit­tee late Wednes­day an­nounced a new bi­par­ti­san in­ves­ti­ga­tion in­to risky life sci­ence re­search, amid on­go­ing ten­sions with Chi­nese bio­phar­ma ser­vice providers with a new bill tar­get­ing the com­pa­nies mak­ing head­way in both the House and Sen­ate.

Sens. Gary Pe­ters (D-MI) and Rand Paul (R-KY) said they plan to hold hear­ings and dig in­to every­thing from “high-risk life sci­ence re­search, biode­fense, syn­thet­ic bi­ol­o­gy, biosafe­ty and biose­cu­ri­ty laps­es,” to “ear­ly warn­ing ca­pa­bil­i­ties for emerg­ing out­breaks or pos­si­ble at­tacks, and po­ten­tial ori­gins of the COVID-19 pan­dem­ic.”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER